Fundraising FoxAchieve Life Sciences
NASDAQ: ACHVVancouver, B.C., US · Delaware corporation · 4 known investors
Find your way into Achieve Life Sciences
Sign up to see every warm intro you have to Achieve Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Achieve Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Achieve is a specialty pharmaceutical company developing and commercializing cytisinicline as a treatment for nicotine dependence, aimed at helping people who smoke quit. It targets the global smoking health problem through this drug candidate.
Founders & leadership
Board
Investors · 4
How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: Vivo Capital's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$18.9M disclosed across 1 round · 2022
▶$18.9MraisedDec 2022 · 16 investors · BiotechnologyRule 506(b)
- Cindy JacobsExecutive Officer, Director
- Anthony ClarkeExecutive Officer
- Bridget MartellDirector
- Martin MattinglyDirector
- Jaime XinosExecutive Officer
- Vaughn HimesDirector
- Donald JosephDirector
- John BencichExecutive Officer, Director
- Richard StewartDirector
- Jay MoyesDirector
- Offering amount
- $25M
- Amount sold
- $18.9M
- Finders' fees
- $756K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Achieve Life Sciences.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $320K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Achieve Life Sciences do?
- Achieve is a specialty pharmaceutical company developing and commercializing cytisinicline as a treatment for nicotine dependence, aimed at helping people who smoke quit. It targets the global smoking health problem through this drug candidate.
- Who founded Achieve Life Sciences?
- Achieve Life Sciences was founded by Anthony Clarke, Richard Stewart.
- Who are Achieve Life Sciences's investors?
- Achieve Life Sciences's investors include LifeSci Venture Partners, venBio Partners, Vivo Capital, Frazier Life Sciences.
- How much funding has Achieve Life Sciences raised?
- Achieve Life Sciences has disclosed $18.9M raised across 1 round.
- Where is Achieve Life Sciences headquartered?
- Achieve Life Sciences is headquartered in Vancouver, B.C., US.